Are patients with anti-ANCA-AAV entered into clinical trials representative of patients followed in observational cohorts?

被引：0

作者：

Pagnoux, Christian ^{[1
,2
]}

Carette, Simon ^{[1
]}

Khalidi, Nader A. ^{[3
]}

Cuthberston, David ^{[4
]}

Fortin, Paul ^{[1
]}

Hoffman, Gary ^{[5
]}

Langford, Carol ^{[5
]}

Monach, Paul A. ^{[7
]}

Mouthon, Luc ^{[2
]}

Seo, Phil ^{[6
]}

Specks, Ulrich ^{[7
]}

Ytterberg, Steven ^{[7
]}

Merkel, Peter A. ^{[8
]}

Guillevin, Loic ^{[2
]}

机构：

[1] Univ Toronto, Toronto, ON, Canada

[2] Univ Paris 05, Hop Cochin, Paris, France

[3] McMaster Univ, Hamilton, ON, Canada

[4] Univ S Florida, Tampa, FL USA

[5] Ctr Vasculitis Care & Res, Cleveland, OH USA

[6] Johns Hopkins Vasculitis Ctr, Baltimore, MD USA

[7] Mayo Clin, Rochester, NY USA

[8] Boston Univ, Vasculitis Ctr, Boston, MA 02215 USA

来源：

CLINICAL AND EXPERIMENTAL IMMUNOLOGY | 2011年 / 164卷

关键词：

D O I：

暂无

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：81 / 82

页数：2

共 50 条

[1] Are Patients with ANCA-Associated Vasculitis Entered In Clinical Trials Representative of Patients Followed In Observational Cohorts?
Pagnoux, Christian
Carette, Simon
Khalidi, Nader A.
Cuthberston, David
Fortin, Paul R.
Hoffman, Gary S.
Langford, Carol A.
Monach, Paul A.
Mouthon, Luc
Seo, Philip
Specks, Ulrich
Ytterberg, Steven R.
Merkel, Peter A.
Guillevin, Loic
The Vcrc
ARTHRITIS AND RHEUMATISM, 2011, 63 (10): : S923 - S923
[2] Cluster analysis and clinical phenotypes of anti-ANCA-AAV
Mahr, Alfred
Katsahian, Sandrine
Varet, Hugo
Guillevin, Loic
Hagen, E. Christiaan
Hoglund, Peter
Merkel, Peter A.
Pagnoux, Christian
Rasmussen, Niels
Westman, Kerstin
Jayne, David
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 : 80 - 81
[3] Comparability of patients with ANCA-associated vasculitis enrolled in clinical trials or in observational cohorts
Pagnoux, C.
Carette, S.
Khalidi, N. A.
Walsh, M.
Hiemstra, T. F.
Cuthbertson, D.
Langford, C.
Hoffman, G.
Koening, C. L.
Monach, P. A.
Moreland, L.
Mouthon, L.
Seo, P.
Specks, U.
Ytterbere, S.
Westman, K.
Hoglund, P.
Harper, L.
Flossmann, O.
Luqmani, R.
Savage, C.
Rasmussen, N.
de Groot, K.
Tesar, V.
Jayne, D.
Merkel, P. A.
Guillevin, L.
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2015, 33 (02) : S77 - S83
[4] WHY ARE PATIENTS NOT ENTERED INTO CLINICAL-TRIALS
SCHIPPER, H
CANCER INVESTIGATION, 1985, 3 (01) : 97 - 98
[5] Patients entered into MRC AML trials are biologically representative of the totality of the disease in the UK
Moorman, AV
Roman, E
Cartwright, RA
Morgan, GJ
CLINICAL AND LABORATORY HAEMATOLOGY, 2002, 24 (04): : 263 - 265
[6] Patients enrolled in randomised clinical trials are not representative of critically ill patients in clinical practice: Observational study focus on tigecycline
Zimmermann, Johannes B.
Horscht, Julia J.
Weigand, Markus A.
Bruckner, Thomas
Martin, Eike O.
Hoppe-Tichy, Torsten
Swoboda, Stefanie
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2013, 42 (05) : 436 - 442
[7] A novel anti-neutrophil antibody in serum of patients with MPO-ANCA-AAV
Suzuki, Koya
Nagao, Tomokazu
Itabashi, Mituyo
Sugamata, Ryuichi
Yamazaki, Yuji
Yumura, Wako
Tsukita, Sachiko
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 2011, 164 : 96 - 96
[8] Stroke patients treated by thrombectomy in real life differ from cohorts of the clinical trials: a prospective observational study
Deb-Chatterji, Milani
Pinnschmidt, Hans
Flottmann, Fabian
Leischner, Hannes
Alegiani, Anna
Brekenfeld, Caspar
Fiehler, Jens
Gerloff, Christian
Thomalla, Goetz
BMC NEUROLOGY, 2020, 20 (01)
[9] Stroke patients treated by thrombectomy in real life differ from cohorts of the clinical trials: a prospective observational study
Milani Deb-Chatterji
Hans Pinnschmidt
Fabian Flottmann
Hannes Leischner
Anna Alegiani
Caspar Brekenfeld
Jens Fiehler
Christian Gerloff
Götz Thomalla
BMC Neurology, 20
[10] How important is the role of the research nurse in the care of patients entered into cancer clinical trials?
Varcoe, SM
Elliott, ME
EUROPEAN JOURNAL OF CANCER, 1999, 35 : S10 - S10

← 1 2 3 4 5 →